Active — Not RecruitingNot Applicable

Heart Rate, Baroreflex Sensitivity and Cardiovascular Morbidity and Mortality in the Population

France10,157 participantsStarted 2008-05-13

Plain-language summary

The aim of the present Paris Prospective Study III (PPS3) is (1) to assess the determinants of the regulation of heart rate and blood pressure variations and carotid properties (under different physiologic stimulations) and (2) to evaluate the respective contribution of heart rate, blood pressure variations and carotid properties to cardiovascular morbidity and mortality including sudden death during 10 years at least in healthy considered subjects.

Who can participate

Age range50 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 50-75 years, French speaking, given consent for genetic analysis, * written consent for participating in the study Exclusion Criteria: * \<50 years and \>75 years, * no French speaking, * current pregnancy, * chronic severe disease, * disagreement for genetic analysis, * step test considered as non possible or non advisable by medical decision.

What they're measuring

cardiovascular disease (CVD)

Timeframe: through study completion, an average of 24 years

Trial details

NCT IDNCT00741728

SponsorInstitut National de la Santé Et de la Recherche Médicale, France

Sponsor typeOTHER_GOV

Study typeOBSERVATIONAL

Primary completion2032-06

View on ClinicalTrials.gov More Community Based Study trials